Golden Hour Treatment With tPA (Tissue-Type Plasminogen Activator) in the BEST-MSU Study. Mackey J, Yamal JM, Parker SA, Silnes K, et al. Stroke 2023;54:415-425.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Mackey J, Yamal JM, Parker SA, Silnes K, et al. Golden Hour Treatment With tPA (Tissue-Type Plasminogen Activator) in the BEST-MSU Study. Stroke 2023;54:415-425.
PMID: 36689579